Coronavirus (COVID-19) and Employee Health

Article ID: e160721188688 Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Background: The coronavirus, which is now spreading around the world as a pandemic has caused more than 30 million cases and nearly 1000,000 deaths worldwide. No vaccine has been used against the virus so far, and there are no specific drugs to cure the patients. This paper examines the impact of the COVID-19 pandemic on employees’ health, either in the governmental or private sector. The aim of this study was to protect the staff against the disease in pandemic conditions by identifying the main ways to keep employees healthy during the COVID-19 pandemic in different scenarios.

Methods: This paper is a perspective article, and different scenarios were assessed for the consideration of employee health.

Results: Two scenarios could be considered first, when the vaccine against COVID-19 is not available for the prevention and the second scenario is that the vaccine is available for all in the world. In both cases, maintaining the health of the staff will be different. If the coronavirus disease will continue to occur in humans till the access to a safe vaccine is not possible, emphasis on maintaining health standards, keeping a social distance, and wearing the mask are the only ways to deal with this life threatening disease. Even after the preparation of the vaccine, maintaining health standards, keeping a social distancing, and wearing the mask must be continued.

Conclusion: The high level of health for the employee must be considered by governments in different scenarios.

Keywords: Coronavirus, COVID-19, employee health, pandemic, vaccine, health.

[1]
Rolling updates on coronavirus disease (COVID-19). Updated 31 July 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
[2]
Dasaraju PV, Liu C, Baron S. Infections of the respiratory system. In: Baron S, Ed.Medical Microbiology. 4th ed. Galveston, TX 1996. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8142/.
[3]
Time. All your coronavirus questions, answered. Available from: https://time.com/5820118/coronavirus-questions-answered/.
[4]
World Health Organization. Coronavirus disease (COVID-19) situation report – 118. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200517-covid-19-sitrep-118.pdf?sfvrsn=21c0dafe_6.
[6]
CDC. Healthcare Workers: Information on COVID-19. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html.
[7]
Ningthoujam R. COVID 19 can spread through breathing, talking, study estimates. Curr Med Res Pract 2020; 10(3): 132-3.
[http://dx.doi.org/10.1016/j.cmrp.2020.05.003] [PMID: 32391407]
[8]
The Wall Street Journal. Corona virus is found in semen of Covid-19 patients. 2020. Available from: https://www.wsj.com/articles/coronavirus-is-found-in-semen-of-covid-19-patients-11588863600.
[9]
[10]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[11]
Cheng Y, Wong R, Soo YOY, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005; 24(1): 44-6.
[http://dx.doi.org/10.1007/s10096-004-1271-9] [PMID: 15616839]
[12]
Ye M, Fu D, Ren Y, et al. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol 2020; 92: 1890-901.
[http://dx.doi.org/10.1002/jmv.25882] [PMID: 32293713]
[13]
[14]
Chang T-H, Wu J-L, Chang L-Y. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc 2020; 119(5): 982-9.
[http://dx.doi.org/10.1016/j.jfma.2020.04.007] [PMID: 32307322]
[15]
DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020. Available from: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf.
[16]
Long Q, Liu B, Deng H, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020; 26(6): 845-8.
[http://dx.doi.org/10.1038/s41591-020-0897-1]
[17]
Johns Hopkins. What is herd immunity and how can we achieve it with covid-19?. Available from: https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html.
[18]
World Health Organization; Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (‎MERS-CoV)‎ infection: interim guidance: updated October 2019. Available from: https://apps.who.int/iris/handle/10665/174652.
[19]
Sun B, Feng Y, Mo X. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect 202; 9(1): 940-8.
[http://dx.doi.org/10.1080/22221751.2020.1762515]
[20]
Vaidyanathan G. India will supply coronavirus vaccines to the world - will its people benefit? Nature 2020; 585(7824): 167-8.
[http://dx.doi.org/10.1038/d41586-020-02507-x] [PMID: 32884143]
[21]
Wang J, Pan L, Tang S, Ji JS, Shi X. Mask use during COVID-19: A risk adjusted strategy. Environ Pollut 2020; 266(Pt 1): 115099.
[http://dx.doi.org/10.1016/j.envpol.2020.115099] [PMID: 32623270]
[22]
Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global - travel and the 2019 novel coronavirus. Travel Med Infect Dis 2020; 33: 101578.
[http://dx.doi.org/10.1016/j.tmaid.2020.101578] [PMID: 32044389]
[23]
TUC. Covid-19 Coronavirus - Guidance for unions (updated 04 Jan 2021). Available from: https://www.tuc.org.uk/resource/covid-19-coronavirus-guidance-unions-updated-16-april.
[24]
EU-OSHA. COVID-19 and long COVID: step-by-step guidance on getting back to work for managers and workers. 2020. Available from: https://osha.europa.eu/en/highlights/coronavirus-disease-covid-19-outbreak-and-workplace-safety-and-health.
[25]
Pothiawala S. Psychological impact of the covid-19 on health care workers in the emergency department. Adv J Emerg Med 2020; 4(2s): e58.
[http://dx.doi.org/10.22114/ajem.v0i0.397]